F

FATE

Fate Therapeutics Inc

2.78

Jul 17 • 03:59PM ET +0.05 (1.83%)

2.77

Aftermarket • 05:18PM ET -0.01 (-0.36%)

Healthcare Biotechnology USA Small NASD

Peers: ALLO CCCC ALXO BCYC CLLS FHTX CHRS IMRX REPL ZNTL

| Held by: VTI VXF SCHA IWC VHT PRFZ SCHB AVSC DFMC QQQS

Scroll to Statements

Index	-
Market Cap	324.03M
Enterprise Value	225.99M
Income	-129.91M
Sales	6.32M
Book/sh	1.55
Cash/sh	1.50
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	161
IPO	Oct 01, 2013

P/E	-
Forward P/E	-
PEG	-
P/S	51.27
P/B	1.80
P/C	1.85
P/FCF	-
EV/EBITDA	-
EV/Sales	35.76
Quick Ratio	5.85
Current Ratio	5.85
Debt/Eq	0.43
LT Debt/Eq	0.40
Option/Short	Yes / Yes

EPS (ttm)	-1.09
EPS next Y	-1.03
EPS next Q	-0.27
EPS this Y	5.93%
EPS next Y	4.70%
EPS next 5Y	2.41%
EPS past 3/5Y	26.67% 11.42%
Sales past 3/5Y	-58.98% -26.71%
EPS Y/Y TTM	26.97%
Sales Y/Y TTM	-52.64%
EPS Q/Q	18.19%
Sales Q/Q	-20.26%
Earnings	May 13 BMO
EPS/Sales Surpr.	7.14% -12.93%

Insider Own	5.16%
Insider Trans	-0.90%
Inst Own	60.76%
Inst Trans	3.38%
ROA	-38.01%
ROE	-55.50%
ROIC	-51.60%
Gross Margin	-97.69%
Oper. Margin	-2207.47%
Profit Margin	-2056.79%
SMA20	4.61%
SMA50	18.22%
SMA200	83.69%
Trades

Shs Outstand	116.27M
Shs Float	110.55M
Short Float	6.72%
Short Ratio	1.80
Short Interest	7.43M
52W High	3.23 -13.93%
52W Low	0.91 205.49%
Volatility	9.54% 11.66%
ATR (14)	0.27
RSI (14)	55.74
Beta	2.52
Rel Volume	0.41
Avg Volume	4.13M
Volume	1,692,627

Perf Week	-10.32%
Perf Month	46.32%
Perf Quarter	102.92%
Perf Half Y	157.41%
Perf YTD	182.92%
Perf Year	141.74%
Perf 3Y	-40.34%
Perf 5Y	-96.46%
Perf 10Y	55.31%
Recom	2.00
Target Price	5.41
Prev Close	2.73
Price	2.78
Change	1.83%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 1 minute for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)